🇨🇦 Abdominal wall block with liposomal bupivicaine in Canada

Abdominal wall block with liposomal bupivicaine (Abdominal wall block with liposomal bupivicaine) regulatory status in Canada.

Marketing authorisation

Abdominal wall block with liposomal bupivicaine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Abdominal wall block with liposomal bupivicaine approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Abdominal wall block with liposomal bupivicaine in Canada?

University of California, Los Angeles is the originator. The local marketing authorisation holder may differ — check the official source linked above.